2015
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal Of Medicine 2015, 373: 145-153. PMID: 26106946, DOI: 10.1056/nejmoa1406235.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsPaclitaxel-coated balloonPeripheral artery diseasePercutaneous transluminal angioplastyPrimary patencyArtery diseaseTransluminal angioplastyStandard angioplastyStandard balloonSymptomatic femoropopliteal peripheral artery diseaseFemoropopliteal peripheral artery diseasePrimary efficacy end pointPrimary safety end pointEnd pointSignificant between-group differencesComposite of freedomPrimary safety eventsSymptomatic intermittent claudicationEfficacy end pointSafety end pointFemoropopliteal artery diseaseProportion of patientsSignificant atherosclerotic lesionsBetween-group differencesRate of death
1998
Modulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease
Caulin-Glaser T, Farrell W, Pfau S, Zaret B, Bunger K, Setaro J, Brennan J, Bender J, Cleman M, Cabin H, Remetz M. Modulation of Circulating Cellular Adhesion Molecules in Postmenopausal Women With Coronary Artery Disease. Journal Of The American College Of Cardiology 1998, 31: 1555-1560. PMID: 9626834, DOI: 10.1016/s0735-1097(98)00145-4.Peer-Reviewed Original ResearchConceptsE2 replacement therapyCoronary artery diseaseVascular cell adhesion molecule-1Cellular adhesion moleculesPostmenopausal womenAdhesion molecule-1Premenopausal womenArtery diseaseCardioprotective effectsInflammatory responseAdhesion moleculesMolecule-1Incidence of CADControl groupInflammatory cytokine-induced expressionIntercellular adhesion molecule-1Expression of CAMsCell adhesion molecule-1Consecutive eligible subjectsAssociation of estrogenEndothelial cell activationCytokine-induced expressionFemale control groupSignificant increaseEnzyme-linked immunoabsorbant assay
1993
Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography
Haronian H, Remetz M, Sinusas A, Baron J, Miller H, Cleman M, Zaret B, Wackers F. Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: Comparison with coronary angiography. Journal Of The American College Of Cardiology 1993, 22: 1033-1043. PMID: 8409038, DOI: 10.1016/0735-1097(93)90413-u.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryClinical ProtocolsCollateral CirculationCoronary AngiographyCoronary DiseaseEvaluation Studies as TopicFemaleHumansMaleMiddle AgedMyocardial InfarctionObserver VariationPredictive Value of TestsPrognosisReproducibility of ResultsRisk FactorsSeverity of Illness IndexTechnetium Tc 99m SestamibiTomography, Emission-Computed, Single-PhotonConceptsMyocardial risk areaCoronary angiographyCoronary angioplastyQuantitative myocardial perfusionMyocardial perfusionMyocardial areaPercutaneous transluminal coronary angioplastyAngiographic risk scoresSmall risk areasTransluminal coronary angioplastyCoronary artery diseaseCoronary artery stenosisInitial myocardial uptakeAngioplasty balloon inflationArtery diseaseLeft anteriorNonperfused areaArtery stenosisCoronary anatomyCoronary arteryBalloon inflationPatient managementMyocardial uptakeRisk scoreAngioplasty
1989
Mild mitral insufficiency is a marker of impaired left ventricular performance in aortic stenosis
Schulman D, Remetz M, Elefteriades J, Frances C. Mild mitral insufficiency is a marker of impaired left ventricular performance in aortic stenosis. Journal Of The American College Of Cardiology 1989, 13: 796-801. PMID: 2926033, DOI: 10.1016/0735-1097(89)90218-0.Peer-Reviewed Original ResearchConceptsAortic stenosisEjection fractionGroup 2Mitral insufficiencyGroup 1Ventricular performanceEnd-systolic volume index ratioControl groupEnd-systolic volume indexSignificant coronary artery diseaseEnd-systolic wall stressImpaired left ventricular performanceGroup 2 patientsMild mitral insufficiencyPure aortic stenosisAortic valve replacementAortic valve areaCoronary artery diseaseLeft ventricular functionEnd-systolic stressLeft ventricular performanceWall stressCardiac indexValve replacementArtery disease
1988
Recovery of severe ischemic ventricular dysfunction after coronary artery bypass grafting
Brill D, Deckelbaum L, Remetz M, Soufer R, Elefteriades J, Zaret B. Recovery of severe ischemic ventricular dysfunction after coronary artery bypass grafting. The American Journal Of Cardiology 1988, 61: 650-651. PMID: 3257840, DOI: 10.1016/0002-9149(88)90784-9.Peer-Reviewed Original ResearchConceptsWall motion abnormalitiesVentricular dysfunctionLeft ventricularMotion abnormalitiesReversible wall motion abnormalitiesSevere coronary artery diseaseVentricular wall motion abnormalitiesIschemic ventricular dysfunctionReversible ventricular dysfunctionCoronary artery bypassCoronary artery diseasePeriod of ischemiaArtery bypassIschemic dysfunctionArtery diseaseHibernating myocardiumMyocardial infarctionMyocardial scarDysfunctionFibrous tissueRecent evidencePatientsComplete reversalAbnormalitiesRevascularization